With inclusion in both the ESC and AHA/ACC clinical guidelines as a recommended option for when symptoms persist after first-line therapy, CAMZYOSis a standard of care for NYHA class II-III ...
Medpage Today on MSN4h
Inching Toward a Blood Test for Hypertrophic CardiomyopathyHCM is a relatively common genetic cardiomyopathy that can be a challenge to diagnose, with about one in three patients misdiagnosed as having another cardiomyopathy. Genetic testing identifies a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback